Skip to content
Clinical Trials – home

Rare diseases

Investigational molecules

Locations

Our offerNewsroom

Sponsor

Immunitybio Inc.

United States 9920 Jefferson Boulevard, 90232-3506, United States

About the sponsor

Immunitybio Inc. is involved in clinical research for non-muscle invasive bladder cancer, with attention to carcinoma in situ and high-grade papillary disease.

  • Bladder-sparing treatment strategies
  • Intravesical immunotherapy
  • Non-muscle invasive urothelial malignancy

The sponsor’s research focus includes disease control in early-stage bladder cancer, with clinical interest in cystoscopic assessment, bladder biopsy, and urine cytology as measures of therapeutic response.

About Specializations

Immunitybio Inc. runs clinical trials in conditions such as Non-small cell lung cancer, Bladder transitional cell carcinoma, among others.

All trials

Ongoing trials

Clinical trials registered by this sponsor – none is enrolling right now.

Condition
Country
City
Type of trial
Recruitment status
Quick filters

2 clinical trials

Non-small cell lung cancer

Not yet recruiting
Registered drugNo placebo
Countries:BelgiumBelgium
  • Participants:18–64 years · 65+ years
  • Substances:Atezolizumab
  • Sponsor:Immunitybio Inc.

Bladder transitional cell carcinoma

Not recruiting
Registered drugNo placebo
Countries:GermanyGermany
  • Participants:18–64 years · 65+ years
  • Sponsor:Immunitybio Inc.

Are you running a clinical trial?

Increase visibility for your trials and help patients find your site through our platform.

Join now →
Clinical Trials Concierge

Prefer not to search? Our Concierge searches the trials for you.

Tell us about your condition – we search every trial in Europe and connect you with the right site.